Carlos Gallardo Piqué

Carlos Gallardo joined the pharmaceutical industry 20 years ago when he joined Pfizer based in New York. In 2004, he joined Almirall where he has remained until the present day. First as an executive in different countries and positions ranging from Strategy, Sales, Licensing, M&A and to Country Management. In 2013, he was appointed Board Director. He became Vice Chairman in 2020 and Chairman as of May 2022. In November 2022, he was appointed interim CEO and in light of the very positive evolution and performance, in February 2023 he was appointed CEO. Additionally, Carlos has established a successful career in innovative healthcare technology. He is the founder and CEO of CG Health Ventures, which invests in early-stage digital health and medtech companies globally, providing a unique blend of operational support and capital. Carlos serves on a number of boards of promising early-stage companies. Before joining the pharmaceutical industry, Carlos worked as an engineer in the automotive industry in logistics and supply chain. He holds a MS in industrial engineering from the Universitat Politècnica de Catalunya and an MBA from Stanford Graduate School of Business.